Why Twist Bioscience Corporation’s (TWST) Stock Is Down 6.94%
As of Monday, November 16, Twist Bioscience Corporation’s TWST share price has dipped by 6.94%, which has investors questioning if this is right time to buy.Tudor Pop
| SECTOR | INDUSTRY |
| Health Care | Biotechnology |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Tudor Pop
Tudor Pop
Rosalio Madrigal
Tudor Pop
Jenna Brashear
| Share Statistics | TWST | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $6,998.1 | $211.8 | 73% |
|
| Shares Out (Mil) | 62.4 | 55.4 | 52% |
|
| Institutional Ownership | 98.9% | 93.0% | 83% |
|
| Float (Mil) | 61.9 | 41.5 | 51% |
|
| Beta | 2.22 | 0.99 | 94% |
|
| Avg Daily Volume (000s) | 2,599 | 553 | 83% |
|
| Price Change (52-week) |
250.2% | 42.8% | 99% |
|
| Growth | TWST | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 33.1% | 13.2% | 91% |
|
| Net Income (5yr) | 11.1% | (10.3%) | 57% |
|
| EPS (5yr) | 18.3% | 15.8% | 65 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | (21.1%) | (15.7%) | 31% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 2 | 3 | 2 | |
| Current EPS | ($0.177) | ($0.550) | $0.920 | |
| Month Ago EPS | ($0.138) | ($0.400) | $0.975 | |
| # Rev Up | 1 | 0 | 0 | |
| # Rev Down | 0 | 0 | 0 | |
| Three Months Ago EPS | ($0.158) | ($0.782) | $0.117 | |
| Year/Year Chg | (68.5%) | (57.7%) | (284.8%) | |
| Financials | TWST | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $432 | $41 | 39% |
|
| Net Income (TTM) (Mil) | ($137) | ($44) | 9% |
|
| EPS (TTM) | ($2.227) | ($1.500) | 14% |
|
| Operating Cash Flow (TTM) (Mil) | ($53) | ($35) | 9% |
|
| Net Cash Flow (TTM) (Mil) | ($84) | $-0 | 17% |
|
| Long-Term Debt (Q1) (Mil) | $100 | $4 | 44% |
|
| Enterprise Value (Q1) (Mil) | $6,348 | $147 | 67% |
|
| Valuation | TWST | Industry Median |
Percentile (All Stocks) |
|
| P/B | 15.70 | 2.01 | 95% |
|
| P/E | na | 17.9 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 1.0 | na |
|
| Ratios | TWST | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 52.4% | 67.9% | 64% |
|
| Net Margin | (28.3%) | (50.6%) | 14% |
|
| ROA | (20.8%) | (47.4%) | 20% |
|
| ROE | (29.6%) | (53.1%) | 20% |
|
| Liabilities to Assets | 33.7% | 29.7% | 25% |
|
| F-Score | 2 | 3 | 7% |
|
Twist Bioscience Corporation did not pass any screens on 11/13/2026.
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors